Other malignant immunoproliferative diseases, in remission
- C88.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- ICD-10-CM C88.81 is a new 2025 ICD-10-CM code that became effective on October 1, 2024.
- This is the American ICD-10-CM version of C88.81 – other international versions of ICD-10 C88.81 may differ.
The following code(s) above C88.81 contain annotation back-references
that may be applicable to C88.81:
- C00-D49 Neoplasms
- C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
- C88 Malignant immunoproliferative diseases and certain other B-cell lymphomas
ICD-10-CM C88.81 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):
- 820 Lymphoma and leukemia with major o.r. Procedures with mcc
- 821 Lymphoma and leukemia with major o.r. Procedures with cc
- 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
Code History
- 2025 (effective 10/1/2024): New code